SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-139654
Filing Date
2017-04-26
Accepted
2017-04-26 16:47:33
Documents
5
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d373708ddefa14a.htm DEFA14A 21121
2 GRAPHIC g373708na001.jpg GRAPHIC 111722
3 GRAPHIC g373708na002.jpg GRAPHIC 210212
4 GRAPHIC g373708na003.jpg GRAPHIC 47583
5 GRAPHIC g373708na004.jpg GRAPHIC 12279
  Complete submission text file 0001193125-17-139654.txt   533161
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36579 | Film No.: 17785001
SIC: 2836 Biological Products, (No Diagnostic Substances)